In other countries
The same active substances on other registers, the same brand first.
- SephienceBrazil · PTC Farmaceutica do Brasil Ltda.Same brand
- Sephience 1000 MG Polvo Oral en SobreSpain · 1000 mg · polvo oral en sobre · Ptc Therapeutics International LimitedSame brand
- Sephience 250 MG Polvo Oral en SobreSpain · 250 mg · polvo oral en sobre · Ptc Therapeutics International LimitedSame brand
- SephienceEuropean Union · PTC Therapeutics International LimitedSame brand
- SephienceCroatiaSame brand
- Sephience 1.000 mg poeder voor oraal gebruik in sachetNetherlands · Poeder voor oraal gebruik · PTC Therapeutics International LimitedSame brand
- Sephience 250 mg poeder voor oraal gebruik in sachetNetherlands · Poeder voor oraal gebruik · PTC Therapeutics International LimitedSame brand
- SephienceUnited States · 1GM/PACKET, 250MG/PACKET · powder · PTC TherapSame brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Sepiapterin
- Strength
- 250 MG / SACHET
- Dosage form
- Powder
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 1 Dec 2025
- Registration
- DIN 02561824
- Marketing authorisation holder
- PTC Therapeutics International Limited
- ATC code
- A16AX28
- Supply
- PRESCRIPTION